The life sciences industry is in a transformational period adjusting to new trends and influences. As the number of blockbuster drugs decreases, many facilities are transitioning from dedicated to multi-product manufacturing facilities, requiring shorter production runs with faster change-overs. At the same time, many unit operations are switching from batch to continuous production which requires…